Precision BioSciences to Participate in Upcoming H.C. Wainwright 26th Annual Global Healthcare Conference
Precision BioSciences, Inc. (DTIL)
Last precision biosciences, inc. earnings: 11/12 07:15 am
Check Earnings Report
Company Research
Source: Business Wire
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, gene insertion, and gene excision, today announced that the Company will participate in a panel discussion and fireside chat at the H.C. Wainwright 26th Annual Global Healthcare Conference taking place September 9-11, 2024 in New York.Details are as follows:Panel: Cutting-Edge Approaches to Viral Hepatitis: Is a Cure on the Horizon?Date: September 9, 2024Time: 11:00-12:00PM ETPresenter: Cassie Gorsuch, Ph.D., Vice President, Gene Therapy DiscoveryFireside Chat:Date: September 10, 2024Time: 5:00-5:30PM ETWebcast Registration: LinkThe Fireside Chat will be available on Precision’s website in the Investors section under Events & Presentations on at investor.precisionbiosciences.com. An archived replay will be available for approxima
Show less
Read more
Impact Snapshot
Event Time:
DTIL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DTIL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DTIL alerts
High impacting Precision BioSciences, Inc. news events
Weekly update
A roundup of the hottest topics
DTIL
News
- Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Celyad Oncology Announces Appointment of Matt Kane as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Wall Street Analysts Think Precision BioSciences (DTIL) Could Surge 277.6%: Read This Before Placing a Bet [Yahoo! Finance]Yahoo! Finance
- Precision BioSciences Strengthens Senior Leadership Team Ahead of Anticipated PBGENE-HBV Clinical Execution [Yahoo! Finance]Yahoo! Finance
- Precision BioSciences Strengthens Senior Leadership Team Ahead of Anticipated PBGENE-HBV Clinical ExecutionBusiness Wire
DTIL
Earnings
- 8/1/24 - Beat
DTIL
Analyst Actions
- 8/22/24 - HC Wainwright
DTIL
Sec Filings
- 9/12/24 - Form 8-K
- 9/3/24 - Form 8-K
- 8/23/24 - Form 4
- DTIL's page on the SEC website